Generated June 10, 2026 at 8:30 PM ET
· Covers June 10 trading day
· 10 of 218 ready 8-Ks selected
· AI-assisted overview
The day's most material filings featured several significant corporate and regulatory events. Danaher completed its $180/share acquisition of Masimo, taking the company private. W.R. Berkley founder and Executive Chairman William R. Berkley passed away, with his son appointed Chairman. Clover Health saw its CMS 2026 Star Rating recalculated to 4.5 Stars following a court ruling. Oracle reported record Q4 revenue of $19.2B, driven by 47% cloud growth, and raised FY2027 EPS guidance. Other notable items included Nixxy signing a binding LOI for a $1B AI infrastructure platform, Aditxt's subsidiary entering a $150M SPAC merger, and Cullinan Therapeutics announcing positive autoimmune disease clinical data.
leadership
neutral
materiality 0.85
June 10, 2026, 4:15 PM ET
W.R. Berkley Corp founder and Executive Chairman William R. Berkley dies at 80; son named Chairman
- William R. Berkley, founder and Executive Chairman, passed away at age 80.
- Board appointed W. Robert Berkley, Jr. (President and CEO) as Chairman, effective immediately.
- Berkley founded the company in 1967; built it into a Fortune 500 commercial insurer.
BKYI
BIO KEY INTERNATIONAL INC
regulatory
negative
materiality 0.85
June 10, 2026, 5:28 PM ET
BIO-key receives Nasdaq notice for delayed 10-Q filing; delisting hearing set for June 16
- Received Nasdaq notice of non-compliance with Listing Rule 5250(c)(1) for failure to timely file Q1 2026 Form 10-Q.
- This is an additional basis for delisting; previously appealed Nasdaq's May 6 determination to suspend trading.
- Hearing before Nasdaq Hearing Panel scheduled for June 16, 2026.
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
regulatory
positive
materiality 0.85
June 10, 2026, 8:31 AM ET
CMS recalculates Clover's 2026 Star Rating to 4.5 Stars after court ruling
- Court granted summary judgment for Clover on May 29, 2026, setting aside the 3.5 Star Rating.
- CMS recalculated the 2026 Star Rating for Contract H5141 (PPO plan) to 4.5 Stars.
- PPO plan covers over 97% of Clover's members; HMO plan (Contract H8010) remains at 4.0 Stars.
M&A
neutral
materiality 1.00
June 10, 2026, 9:41 AM ET
Danaher completes $180/share acquisition of Masimo; Masimo becomes wholly owned subsidiary
- Danaher completed acquisition of Masimo at $180.00 per share in cash on June 10, 2026.
- Masimo common stock ceased trading on Nasdaq; company will deregister under Section 12(b) of the Exchange Act.
- All outstanding Masimo shares cancelled and converted to right to receive $180 cash per share, no interest.
IOVA
IOVANCE BIOTHERAPEUTICS, INC.
regulatory
positive
materiality 0.65
June 10, 2026, 5:01 PM ET
Iovance's Amtagvi granted TGA approval in Australia for advanced melanoma
- Therapeutic Goods Administration of Australia approved Amtagvi for previously treated advanced melanoma.
- Indicated for patients who received anti-PD-1 therapy and, if BRAF V600+, a BRAF/MEK inhibitor.
- Third marketing authorization for Amtagvi; Iovance is authorizing its first Australian treatment center.
GETY
Getty Images Holdings, Inc.
litigation
negative
materiality 0.70
June 10, 2026, 4:15 PM ET
Court grants summary judgment against Getty Images for ~$68M in warrant dispute
- NY State Supreme Court granted summary judgment on June 9, 2026 for warrants with authorization letters; conditional ruling for remaining warrants due Aug 10, 2026.
- Plaintiffs sought $67,811,031 plus pre-judgment interest in the motion.
- Company had previously reserved the full amount in its Q1 2026 10-Q balance sheet.
M&A
positive
materiality 0.85
June 10, 2026, 4:59 PM ET
Nixxy signs binding LOI with Tachyon9 for $1B AI infrastructure platform
- Planned investment of ~$1B into Nakota Project (Williston, ND) for up to 1GW capacity; first 150MW expected by Q2 2027.
- Binding LOI includes $5B GPU financing MoU, $64M in hard assets, and a $75M private placement.
- Combined company expected to trade under TACC on NASDAQ; Nixxy to divest communications business post-closing.
M&A
positive
materiality 0.80
June 10, 2026, 5:30 PM ET
Aditxt subsidiary Ignite signs $150M business combination with SPAC Copley Acquisition
- Ignite Proteomics to merge with SPAC Copley Acquisition Corp at $150M equity value; Ignite holders get Pubco stock at $10/sh.
- Aditxt parent guarantees Ignite's obligations under the Business Combination Agreement via Side Letter.
- Closing conditions include minimum $15M cash from SPAC trust plus financings, and $7.5M from Ignite; deadline Sep 30, 2026.
earnings
positive
materiality 0.85
June 10, 2026, 4:13 PM ET
Oracle reports record Q4 revenue $19.2B, cloud up 47%; RPO $638B; raises FY2027 EPS guidance
- Q4 GAAP EPS $1.45 (+21%), non-GAAP $2.11 (+24%); revenue $19.2B (+21%).
- Q4 cloud revenue $9.9B (+47%); IaaS $5.8B (+93%), SaaS $4.1B (+10%).
- FY2026 total revenue $67.4B (+17%); non-GAAP EPS $7.63 (+27%).
CGEM
Cullinan Therapeutics, Inc.
other material
positive
materiality 0.90
June 10, 2026, 7:32 AM ET
Cullinan Therapeutics reports positive clinical data for CLN-978 and velinotamig in autoimmune diseases
- CLN-978 achieved DAS28-ESR remission in a rituximab-refractory RA patient, reducing score from 4.0 to 2.2 at week 4.
- First three SLE patients on CLN-978 multi-dose showed safety consistent with EULAR 2026 data; rapid proteinuria improvement supports lupus nephritis trial.
- Velinotamig (BCMA TCE) induced complete renal responses in two SLE patients; SLEDAI-2K scores dropped to 0 and 2 at week 8.